当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析

天坛生物

(600161)

  

流通市值:233.73亿  总市值:233.73亿
流通股本:19.77亿   总股本:19.77亿

天坛生物(600161)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.79亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1549695.97万元,未分配利润708112.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1667542.08万元,负债117846.12万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,141,703,634.536,168,036,314.634,465,071,868.983,110,392,965.34
营业总成本949,243,685.914,315,509,249.083,110,810,892.922,079,476,311.38
其他经营收益
营业利润223,388,690.741,837,307,995.591,354,283,536.851,041,961,680.23
利润总额223,217,439.741,822,723,792.41,347,397,281.361,038,370,155.27
净利润179,093,258.661,489,882,179.71,120,457,127.99865,800,086.14
每股收益
其他综合收益1,620,701.85---
综合收益总额180,713,960.511,489,882,179.71,120,457,127.99865,800,086.14
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计8,353,096,535.098,272,166,627.478,271,318,830.988,265,558,876.44
非流动资产:
非流动资产合计8,322,324,311.458,310,848,974.048,279,554,513.918,256,258,173.31
资产总计16,675,420,846.5416,583,015,601.5116,550,873,344.8916,521,817,049.75
流动负债:
流动负债合计947,296,437.831,034,639,712.241,375,250,314.291,293,239,592.01
非流动负债:
非流动负债合计231,164,712.49232,130,153.56228,579,686.6238,439,458.81
负债合计1,178,461,150.321,266,769,865.81,603,830,000.891,531,679,050.82
所有者权益(或股东权益):
归属于母公司股东权益合计11,862,653,860.4611,735,167,115.1411,463,047,833.7611,573,529,356.31
股东权益合计15,496,959,696.2215,316,245,735.7114,947,043,34414,990,137,998.93
负债和股东权益合计16,675,420,846.5416,583,015,601.5116,550,873,344.8916,521,817,049.75
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,027,327,105.694,815,402,695.773,158,646,299.761,786,497,499.46
经营活动现金流出小计1,042,835,301.724,476,656,037.143,041,751,271.691,988,402,049.58
经营活动产生的现金流量净额-15,508,196.03338,746,658.63116,895,028.07-201,904,550.12
投资活动产生的现金流量:
投资活动现金流入小计541,463,589.7746,536,293.99737,239,185.26737,180,887.66
投资活动现金流出小计987,146,547.77622,181,434.31450,530,338.98325,460,519.56
投资活动产生的现金流量净额-445,682,958.07124,354,859.68286,708,846.28411,720,368.1
筹资活动产生的现金流量:
筹资活动现金流入小计86,953,347.1286,925,081.38252,966,301.4242,137,862.63
筹资活动现金流出小计1,101,139.67729,320,770.18725,128,995.46315,178,569.81
筹资活动产生的现金流量净额85,852,207.43-442,395,688.8-472,162,694.04-273,040,707.18
汇率变动对现金及现金等价物的影响-14,958.93-28,934.14-9,499.67-2,279.48
现金及现金等价物净增加额-375,353,905.620,676,895.37-68,568,319.36-63,227,168.68
期末现金及现金等价物余额1,068,243,894.811,443,597,800.411,354,352,585.681,359,693,736.36
补充资料:
现金及现金等价物的净增加额-20,676,895.37--63,227,168.68
最新报告期:2026-05-19
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中邮证券盛丽华0.470.520.612026-05-19
野村东方国际证券孔令岩0.600.690.802026-05-07
诚通证券李志新0.530.620.782026-04-29
兴业证券东楠,孙媛媛,黄翰漾0.640.710.802026-04-24
国投证券胡雨晴0.560.620.682026-04-02
TOP↑